Get ready for more merger mania in pharma sector the rest of the year
August 09, 2022 at 14:43 PM EDT
Pfizer’s $5.4 billion acquisition of Global Blood Therapeutics is the latest sign that cash-flush drug makers are ready to make some deals.
